The 20 Best Thymic Epithelial Tumor Doctors Near Me in San Francisco, CA

Peter Anastassiou is a Thoracic Surgeon practicing medicine in San Francisco, California. Dr. Anastassiou is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Esophageal Perforation, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Advanced Bronchoscopy. Dr. Anastassiou is board certified in Thoracic And Cardiac Surgery. Dr. Anastassiou is currently accepting new patients.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is rated as a Distinguished provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma. Dr. Gubens is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gubens is currently accepting new patients.

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Meyer is board certified in Radiology Diagnostic Radiology. Dr. Meyer is currently accepting new patients.

Binh Trinh is a General Surgeon and a Thoracic Surgeon practicing medicine in San Francisco, California. Dr. Trinh is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Esophageal Perforation, Pleurisy, Non-Small Cell Lung Cancer (NSCLC), and Lung Transplant. Dr. Trinh is board certified in Surgery General Surgery and Thoracic And Cardiac Surgery. Dr. Trinh is currently accepting new patients.

Caring, compassionate, and patient centered care. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Astrocytoma. Dr. Lee is board certified in Radiology Diagnostic Radiology. Dr. Lee is currently accepting new patients.

Lisa Singer is a Radiation Oncologist practicing medicine in San Francisco, California. Dr. Singer is rated as a Distinguished provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Thymic Epithelial Tumor, Pleuropulmonary Blastoma, Lung Cancer, and Breast Cancer.

Dr. Jasleen Kukreja is a cardiothoracic surgeon and director of the Lung Transplant Program at UCSF Medical Center. She is also director of the adult respiratory mechanical circulatory support program. She performs lung transplant surgery and lung volume reduction surgery for emphysema, and treats patients with tumors of the chest, including lung cancer, esophageal cancer, mediastinal tumors and mesothelioma. Kukreja is the associate director of UCSF's lung transplant research division of cardiothoracic surgery. Kukreja earned a medical degree at the David Geffen School of Medicine at UCLA. She completed residencies in general surgery at Brigham and Women's Hospital in Boston and in cardiothoracic surgery at UCSF. She completed fellowships in general surgery and thoracic surgery at Brigham and Women's Hospital, and also completed extensive training in designing clinical trials, studies that evaluate potential treatments' safety and efficacy. She has a master's degree in public health from the Harvard T.H. Chan School of Public Health. Kukreja has received many professional honors, including the Pharmacia/Upjohn Trauma Research Competition Award, John A. Mannick Research Award and an excellence in teaching award from Harvard Medical School. Dr. Kukreja is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Emphysema, Systemic Sclerosis (SSc), Lung Transplant, and Endoscopy. Dr. Kukreja is board certified in American Board Of Thoracic Surgery, Thoracic And Cardiac Surgery. Dr. Kukreja is currently accepting new patients.

Alexander Geng is a Radiologist and a Radiation Oncologist practicing medicine in San Francisco, California. Dr. Geng is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Neuralgia, Gallbladder Adenocarcinoma, and Breast Cancer. Dr. Geng is board certified in Radiology Radiation Oncology. Dr. Geng is currently accepting new patients.

Dr. Johannes Kratz is a thoracic surgeon who specializes in treating disorders of the trachea, chest wall, lung, esophagus and mediastinum (the space between the lungs containing the heart and other structures). He directs UCSF's program for advanced minimally invasive thoracic surgery. Kratz's research interests include robotic surgery outcomes, lung and esophageal cancers, biomarkers to personalize lung cancer treatment and immunotherapies for thoracic tumors. His current research focuses on understanding the molecular and genetic profiles of high-risk tumors in early stages and developing targeted therapies to treat them. While a surgical research fellow at the UCSF Thoracic Oncology Laboratory, Kratz developed a test that more accurately predicts outcomes for patients with early-stage lung cancer. Now available to patients, this test has improved outcomes for those with high-risk lung cancer detected early. Kratz earned his medical degree at Harvard Medical School, graduating magna cum laude. He completed a general surgery residency at Massachusetts General Hospital, followed by a fellowship in cardiothoracic surgery at UCSF. He also has a master's degree in philosophy from Stanford University. Kratz is a member of the American College of Surgeons, Society of Thoracic Surgeons, Massachusetts Medical Society and American Society of Clinical Oncology. In 2017, he received a UCSF Health Exceptional Physician Award. He is the Van Auken Endowed Chair in Thoracic Oncology at UCSF. Dr. Kratz is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Fibrosing Mediastinitis, Thymectomy, and Endoscopy. Dr. Kratz is board certified in American Board Of Thoracic Surgery, Thoracic And Cardiac Surgery and American Board Of Surgery, General Surgery. Dr. Kratz is currently accepting new patients.

Thierry Jahan is an Oncologist practicing medicine in San Francisco, California. Dr. Jahan is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, and Lung Cancer.

Ari Baron is an Oncologist practicing medicine in San Francisco, California. Dr. Baron is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Liver Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Daniel Null is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Null is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hidradenitis Suppurativa, Chronic Cough, Maturity Onset Diabetes of the Young, and Familial Hypertension. Dr. Null is board certified in American Board Of Internal Medicine, Internal Medicine. Dr. Null is currently accepting new patients.

David Jablons is a Thoracic Surgeon practicing medicine in San Francisco, California. Dr. Jablons is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymectomy, and Endoscopy.

Dr. Alexander Gottschalk, an expert in radiation treatment, specializes in caring for patients with lung cancer, prostate cancer and sarcoma. He directs UCSF's program in CyberKnife surgery, in which a flexible robotic arm is used to precisely deliver high doses of radiation. He uses CyberKnife and other forms of stereotactic body radiation therapy to treat cancers of the lung or prostate, as well as cancer that has spread to the bones or lymph nodes. Gottschalk earned both his medical degree and doctorate in pathology at the University of Chicago. He completed a residency in radiation oncology at UCSF. Gottschalk has received numerous awards and research grants, including a research service award and a medical scientist fellowship from the National Institutes of Health, a clinical research grant from the UCSF Helen Diller Family Comprehensive Cancer Center, a scholar award from the Radiological Society of North America and a junior faculty award from the American Society for Radiation Oncology. Dr. Gottschalk is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Prostatectomy. Dr. Gottschalk is board certified in American Board Of Radiology, Radiation Oncology. Dr. Gottschalk is currently accepting new patients.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the chest, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the genetic profile of the patient's cancer to custom-tailor treatment). Cheng leads research centered on developing innovative, next-generation treatments for lung cancer, including therapeutic clinical trials with new targeted therapies and immunotherapies. He is inspired by how research discoveries can lead to tangible benefits for patients. Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School. Cheng is a member of the American Society of Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation, as well as research funding from the National Institutes of Health and National Cancer Institute. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Cheng is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Cheng is currently accepting new patients.

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer. As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment. Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology. Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Dr. Aggarwal is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Melanoma of the Eye, and Muscle Invasive Bladder Cancer. Dr. Aggarwal is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Aggarwal is currently accepting new patients.

Dr. Luai Al Rabadi is a medical oncologist who specializes in caring for patients with cancers of the digestive system. In his research, Al Rabadi focuses on improving cancer outcomes by studying prevention strategies, new therapies, and trends in how patients receive care. His research aims to provide patients with more effective and personalized treatment options. Al Rabadi earned his medical degree from the Royal College of Surgeons in Ireland. He completed a residency in internal medicine at MetroHealth Medical Center, an affiliate of Case Western Reserve University. He completed a fellowship in hematology and medical oncology at Oregon Health & Science University. Outside of work, Al Rabadi enjoys spending time with family, being outdoors, and watching and playing soccer. Dr. Rabadi is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His clinical expertise encompasses Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Acute Monoblastic Leukemia (AmoL). Dr. Rabadi is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Med/Medical Oncology, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Rabadi is currently accepting new patients.

Russell Stanten is a Thoracic Surgeon practicing medicine in Oakland, California. Dr. Stanten is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Stanten is board certified in Thoracic And Cardiac Surgery. Dr. Stanten is currently accepting new patients.